Advanced Cancers Clinical Trials

116 clinical trials for Advanced Cancers across international registries, including 14 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Psilocybin in Cancer Pain Study — RECRUITING · PHASE2
• A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors — RECRUITING · PHASE1
• Clinical Trial of TQB2922 Injection (Subcutaneous Injection) in Patients With Advanced Cancers — RECRUITING · PHASE1
• Personalized Oncogenomics (POG) Program of British Columbia — RECRUITING · NA
• A PHASE 1, FIRST IN HUMAN STUDY OF TORL-4-500 IN PATIENTS WITH ADVANCED CANCER — RECRUITING · PHASE1
• PHASE 1/2 STUDY OF 9-ING-41, A GLYCOGEN SYNTHASE KINASE-3 BETA (GSK-3B) INHIBITOR, AS A SINGLE AGENT AND COMBINED WITH CHEMOTHERAPY, IN PATIENTS WITH REFRACTORY HEMATOLOGIC MALIGNANCIES OR SOLID TUMORS — RECRUITING · PHASE1
• PSILOCYBIN-ASSISTED EXISTENTIAL, ATTACHMENT AND RELATIONAL (PEARL) THERAPY FOR PATIENTS WITH ADVANCED CANCER: A PHASE II OPEN-LABEL TRIAL — RECRUITING · PHASE2
• A PHASE 1, OPEN-LABEL, DOSE FINDING STUDY OF CC-95251, A MONOCLONAL ANTIBODY DIRECTED AGAINST SIRP¿, ALONE AND IN COMBINATION WITH CETUXIMAB IN SUBJECTS WITH ADVANCED SOLID CANCERS — RECRUITING · PHASE1
• "A PHASE 1/2A STUDY OF BMS-986253 IN COMBINATION WITH NIVOLUMAB IN ADVANCED CANCERS." — RECRUITING · PHASE1
• A PHASE II STUDY OF DURVALUMAB AND TREMELIMUMAB IN PATIENTS WITH ADVANCED RARE TUMOURS — RECRUITING · PHASE2
• AN OPEN LABEL, DOSE ESCALATION, SAFETY, AND PHARMACOKINETIC STUDY OF CFI-402257 ADMINISTERED ORALLY TO PATIENTS WITH ADVANCED CANCER — RECRUITING
• A PHASE I STUDY OF LY3076226, A FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH ADVANCED OR METASTATIC CANCER — RECRUITING · PHASE1
• A PHASE I/II MULTICENTER, OPEN-LABEL STUDY OF CLR457, ADMINISTERED ORALLY IN ADULT PATIENTS WITH ADVANCED SOLID MALIGNANCIES — RECRUITING · PHASE1
• A STUDY TO SELECT RATIONAL THERAPEUTICS BASED ON THE ANALYSIS OF MATCHED TUMOR AND NORMAL BIOPSIES WITH ADVANCED MALIGNANCIES. — RECRUITING
• A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• The Effects of Ginseng on Cancer-Related Fatigue — ACTIVE_NOT_RECRUITING · PHASE1
• Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies — TERMINATED · PHASE1
• PSILOCYBIN-ASSISTED EXISTENTIAL, ATTACHMENT AND RELATIONAL (PEARL) THERAPY FOR PATIENTS WITH ADVANCED CANCER: A RANDOMIZED CONTROLLED TRIAL — NOT_YET_RECRUITING
• Safety Study of GL-ONC1, an Oncolytic Virus, in Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• Temsirolimus in Combination With Metformin in Patients With Advanced Cancers — TERMINATED · PHASE1
• A Multicenter, Open Label Phase I Clinical Trial Evaluating the Safety and Pharmacokinetics of TQB2252 Injection in Subjects With Advanced Malignant Tumors — NOT_YET_RECRUITING · PHASE1
• A PHASE 2A SINGLE-ARM PROOF OF CONCEPT STUDY TO INVESTIGATE THE SAFETY AND PRELIMINARY ANALGESIC EFFICACY OF ORAL TRICHOMYLIN® IN MALE AND FEMALE PARTICIPANTS 18 YEARS OF AGE AND ABOVE WITH CANCER AND MODERATE TO SEVERE CANCER-RELATED PAIN — COMPLETED · PHASE2
• Hepatic Impairment Study for Lorlatinib in Cancer Patients — TERMINATED · PHASE1
• Plasmodium Immunotherapy for Advanced Cancers — OTHER · PHASE1
• A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies — COMPLETED · PHASE1
• Clinical Trial of the TQB3602 Capsule Combined With AK105 Injection in Patients With Advanced Cancers — OTHER · PHASE1
• Phase II Study of Ilorasertib (ABT348) in Patients With CDKN2A Deficient Solid Tumors — TERMINATED · PHASE2
• Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea — COMPLETED · PHASE2
• Cordotomy for Refractory Cancer Pain — COMPLETED · NA
• Dasatinib and Crizotinib in Advanced Cancer — COMPLETED · PHASE1
• Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients — COMPLETED · PHASE1
• A PHASE II STUDY OF RP-6306 IN PATIENTS WITH ADVANCED CANCER — COMPLETED · PHASE2
• A Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency — COMPLETED · PHASE2
• MLN9708 and Vorinostat in Patients With Advanced p53 Mutant Malignancies — COMPLETED · PHASE1
• Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis — TERMINATED · PHASE3
• Clinical Trial of the TQB2930 Injection in Patients With Advanced Cancers — OTHER · PHASE1
• PHASE 1/2 STUDY OF BLU-451 IN ADVANCED CANCERS WITH EGFR EXON 20 INSERTION MUTATIONS — NOT_YET_RECRUITING · PHASE1
• Art Therapy in Palliative Care: Study of Identification and Understanding of the Mechanisms of Change in the Patient — COMPLETED · NA
• Rational Therapeutics Based on Matched Tumor and Normal Tissue — COMPLETED
• Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer — TERMINATED · PHASE1
• Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain — COMPLETED · PHASE4
• Genomic Profiling Assay in Phase I — COMPLETED
• Sublingual Fentanyl for the Management of Breakthrough Pain — TERMINATED · PHASE2
• Perception of Palliative Care Encounter — COMPLETED
• STUDY TO ASSESS THE EFFECT OF PF-06946860 ON APPETITE FOLLWOING SUBCUTANEOUS ADMINISTRATION TO PATIENTS WITH ANOREXIA AND ADVANCED CANCER — COMPLETED
• Regorafenib and Cetuximab in Patients With Advanced Malignancy — COMPLETED · PHASE1
• Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer — COMPLETED · PHASE1
• Dexamethasone Dyspnea Study — COMPLETED · PHASE2
• A First in Man Study of MABp1 in Patients With Advanced Cancers — COMPLETED · PHASE1

Refine this search